Neurones S.A. (EPA:NRO)
France · Delayed Price · Currency is EUR 43.25
+0.05 (0.12%)
Jul 31, 2025, 5:35 PM CET
Verve Therapeutics Revenue
In the year 2024, Neurones had annual revenue of 810.35M EUR with 9.33% growth. Neurones had revenue of 407.92M in the half year ending December 31, 2024, with 20.60% growth.
Revenue
810.35M
Revenue Growth
+9.33%
P/S Ratio
1.30
Revenue / Employee
114.34K
Employees
7,087
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 810.35M | 69.18M | 9.33% |
| Dec 31, 2023 | 741.18M | 75.80M | 11.39% |
| Dec 31, 2022 | 665.38M | 85.50M | 14.74% |
| Dec 31, 2021 | 579.88M | 55.39M | 10.56% |
| Dec 31, 2020 | 524.49M | 14.42M | 2.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dassault Systèmes SE | 6.31B |
| Capgemini SE | 22.10B |
| STMicroelectronics | 10.12B |
| Rexel | 19.43B |
| Tatatu | 84.19M |
| VusionGroup | 954.71M |
| Sopra Steria Group | 5.67B |
| Alten | 4.14B |